As of 2026-10-01, the Relative Valuation of Cytokinetics Inc (CYTK) is (186.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 65.91 USD, the upside of Cytokinetics Inc based on Relative Valuation is -382.6%.
The range of the Relative Valuation is (172.10) - (198.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.0x - 30.1x | 28.0x |
| Forward P/E multiples | 26.1x - 30.8x | 28.4x |
| Fair Price | (172.10) - (198.48) | (186.28) |
| Upside | -361.1% - -401.1% | -382.6% |
| Date | P/E |
| 2026-09-30 | -10.00 |
| 2026-09-29 | -9.95 |
| 2026-09-28 | -10.03 |
| 2026-09-25 | -9.81 |
| 2026-09-24 | -9.96 |
| 2026-09-23 | -9.98 |
| 2026-09-22 | -10.25 |
| 2026-09-21 | -10.25 |
| 2026-09-18 | -10.43 |
| 2026-09-17 | -10.60 |
| 2026-09-16 | -10.52 |
| 2026-09-15 | -10.51 |
| 2026-09-14 | -10.99 |
| 2026-09-11 | -11.19 |
| 2026-09-10 | -11.16 |
| 2026-09-09 | -11.24 |
| 2026-09-08 | -11.43 |
| 2026-09-04 | -11.03 |
| 2026-09-03 | -11.21 |
| 2026-09-02 | -10.91 |
| 2026-09-01 | -10.83 |
| 2026-08-31 | -10.75 |
| 2026-08-28 | -10.93 |
| 2026-08-27 | -11.81 |
| 2026-08-26 | -12.01 |
| 2026-08-25 | -11.75 |
| 2026-08-24 | -11.69 |
| 2026-08-21 | -11.65 |
| 2026-08-20 | -11.70 |
| 2026-08-19 | -11.79 |
| 2026-08-18 | -11.54 |
| 2026-08-17 | -11.51 |
| 2026-08-14 | -11.24 |
| 2026-08-13 | -11.14 |
| 2026-08-12 | -11.47 |
| 2026-08-11 | -11.59 |
| 2026-08-10 | -11.75 |
| 2026-08-07 | -11.64 |
| 2026-08-06 | -12.34 |
| 2026-08-05 | -11.96 |
| 2026-08-04 | -11.92 |
| 2026-08-03 | -11.59 |
| 2026-07-31 | -11.70 |
| 2026-07-30 | -12.20 |
| 2026-07-29 | -11.89 |
| 2026-07-28 | -12.05 |
| 2026-07-27 | -12.23 |
| 2026-07-24 | -12.24 |
| 2026-07-23 | -12.42 |
| 2026-07-22 | -12.46 |